company background image
PROB logo

Probi OM:PROB Stock Report

Last Price

SEK 348.00

Market Cap

SEK 4.0b

7D

0.6%

1Y

68.9%

Updated

23 Dec, 2024

Data

Company Financials +

Probi AB (publ)

OM:PROB Stock Report

Market Cap: SEK 4.0b

PROB Stock Overview

Researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. More details

PROB fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 62.02% per year

Risk Analysis

Highly volatile share price over the past 3 months compared to the Swedish market


My Notes

Capture your thoughts, links and company narrative

Probi AB (publ) Competitors

Egetis Therapeutics

OM:EGTX

SEK 2.4b

Hansa Biopharma

OM:HNSA

SEK 2.5b

Devyser Diagnostics

OM:DVYSR

SEK 2.0b

Cereno Scientific

OM:CRNO B

SEK 1.5b

Price History & Performance

Summary of share price highs, lows and changes for Probi
Historical stock prices
Current Share PriceSEK 348.00
52 Week HighSEK 351.00
52 Week LowSEK 181.00
Beta0.47
1 Month Change-0.57%
3 Month Change34.36%
1 Year Change68.93%
3 Year Change-12.34%
5 Year Change56.76%
Change since IPO873.43%

Recent News & Updates

Probi AB (publ)'s (STO:PROB) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Nov 21
Probi AB (publ)'s (STO:PROB) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Recent updates

Probi AB (publ)'s (STO:PROB) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Nov 21
Probi AB (publ)'s (STO:PROB) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Probi's (STO:PROB) Anemic Earnings Might Be Worse Than You Think

Jul 24
Probi's (STO:PROB) Anemic Earnings Might Be Worse Than You Think

There's No Escaping Probi AB (publ)'s (STO:PROB) Muted Revenues Despite A 43% Share Price Rise

Jun 26
There's No Escaping Probi AB (publ)'s (STO:PROB) Muted Revenues Despite A 43% Share Price Rise

Should You Be Adding Probi (STO:PROB) To Your Watchlist Today?

Sep 08
Should You Be Adding Probi (STO:PROB) To Your Watchlist Today?

Estimating The Intrinsic Value Of Probi AB (publ) (STO:PROB)

Aug 12
Estimating The Intrinsic Value Of Probi AB (publ) (STO:PROB)

Is Now The Time To Put Probi (STO:PROB) On Your Watchlist?

May 26
Is Now The Time To Put Probi (STO:PROB) On Your Watchlist?

Probi AB (publ)'s (STO:PROB) Intrinsic Value Is Potentially 19% Below Its Share Price

May 05
Probi AB (publ)'s (STO:PROB) Intrinsic Value Is Potentially 19% Below Its Share Price

Is Probi AB (publ)'s (STO:PROB) Recent Price Movement Underpinned By Its Weak Fundamentals?

Mar 05
Is Probi AB (publ)'s (STO:PROB) Recent Price Movement Underpinned By Its Weak Fundamentals?

Here's Why I Think Probi (STO:PROB) Might Deserve Your Attention Today

Feb 15
Here's Why I Think Probi (STO:PROB) Might Deserve Your Attention Today

Here's What Probi AB (publ)'s (STO:PROB) Shareholder Ownership Structure Looks Like

Jan 29
Here's What Probi AB (publ)'s (STO:PROB) Shareholder Ownership Structure Looks Like

Probi AB (publ)'s (STO:PROB) Intrinsic Value Is Potentially 20% Below Its Share Price

Jan 11
Probi AB (publ)'s (STO:PROB) Intrinsic Value Is Potentially 20% Below Its Share Price

Have Insiders Been Buying Probi AB (publ) (STO:PROB) Shares?

Dec 22
Have Insiders Been Buying Probi AB (publ) (STO:PROB) Shares?

Has Probi AB (publ)'s (STO:PROB) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Dec 03
Has Probi AB (publ)'s (STO:PROB) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Shareholder Returns

PROBSE BiotechsSE Market
7D0.6%-0.1%-2.3%
1Y68.9%13.8%4.6%

Return vs Industry: PROB exceeded the Swedish Biotechs industry which returned 13.8% over the past year.

Return vs Market: PROB exceeded the Swedish Market which returned 4.6% over the past year.

Price Volatility

Is PROB's price volatile compared to industry and market?
PROB volatility
PROB Average Weekly Movement13.0%
Biotechs Industry Average Movement9.9%
Market Average Movement5.6%
10% most volatile stocks in SE Market11.4%
10% least volatile stocks in SE Market3.2%

Stable Share Price: PROB's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: PROB's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
1991157Anita Johansenwww.probi.com

Probi AB (publ) researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. The company conducts research primarily in the fields of mental, digestive, immune, bone, oral, children’s, women’s, and senior health, as well as iron absorption. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, chilled diary and plant based products, frozen desserts and ice-cream, powder formulas, and recovery drinks.

Probi AB (publ) Fundamentals Summary

How do Probi's earnings and revenue compare to its market cap?
PROB fundamental statistics
Market capSEK 3.97b
Earnings (TTM)SEK 10.88m
Revenue (TTM)SEK 630.39m

364.3x

P/E Ratio

6.3x

P/S Ratio

Is PROB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PROB income statement (TTM)
RevenueSEK 630.39m
Cost of RevenueSEK 421.23m
Gross ProfitSEK 209.16m
Other ExpensesSEK 198.27m
EarningsSEK 10.88m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Jan 28, 2025

Earnings per share (EPS)0.96
Gross Margin33.18%
Net Profit Margin1.73%
Debt/Equity Ratio0%

How did PROB perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

136%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 17:22
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Probi AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jakob LembkeABG Sundal Collier Sponsored
null nullABG Sundal Collier Sponsored
Hans MählerHandelsbanken Capital Markets